Amanote Research
Register
Sign In
A Selective FLT3 Inhibitor Shows Clinical Efficacy in AML
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2013-203
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
September 12, 2013
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)